Regulation of glioma cell migration by serine-phosphorylated P311

Neoplasia

Volumn 7, Issue 9, 2005, Pages 862-872

  McDonough, Wendy S ^a   Tran, Nhan L ^a   Berens, Michael E ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Glioma; Integrin; Migration; P311; Phosphorylation

Indexed keywords

AMOTOSALEN; BETA1 INTEGRIN; FILAMIN A; MUSCLE PROTEIN; PROTEIN P311; RAC1 PROTEIN; SERINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; C5ORF13 PROTEIN, HUMAN; CONTRACTILE PROTEIN; FILAMINS; NERVE PROTEIN; ONCOPROTEIN; PROTEIN KINASE C;

AMINO ACID SEQUENCE; ARTICLE; CELL MIGRATION; CELL MOTILITY; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; CANCER INVASION; CELL MOTION; CHEMISTRY; DRUG ANTAGONISM; GENETICS; GLIOMA; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHOSPHORYLATION; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CONTRACTILE PROTEINS; GLIOMA; HUMANS; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN STRUCTURE, TERTIARY; RAC1 GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; SERINE;

EID: 33644877500     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.05190     Document Type: Article

References (45)

1. Giese A, Bjerkvig R, Berens ME, and Westphal M (2003). Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21, 1624-1636.
2. Keles GE and Berger MS (2004). Advances in neurosurgical technique in the current management of brain tumors. Semin Oncol 31, 659-665.
3. McDonough W, Tran N, Giese A, Norman SA, and Berens ME (1998). Altered gene expression in human astrocytoma cells selected for migration: I. Thromboxane synthase. J Neuropathol Exp Neurol 57, 449-455.
4. Mariani L, Beaudry C, McDonough WS, Hoelzinger DB, Demuth T, Ross KR, Berens T, Coons SW, Watts G, Trent JM, et al. (2001). Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neuro-Oncol 53, 161-176.
5. Mariani L, McDonough WS, Hoelzinger DB, Beaudry C, Kaczmarek E, Coons SW, Giese A, Moghaddam M, Seiler RW, and Berens ME (2001). Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res 61, 4190-4196.
6. Studler JM, Glowinski J, and Levi-Strauss M (1993). An abundant mRNA of the embryonic brain persists at a high level in cerebellum, hippocampus and olfactory bulb during adulthood. Eur J Neurosci 5, 614-623.
7. Varshavsky A (1997). The ubiquitin system. Trends Biochem Sci 22, 383-387.
8. Dice JF (1987). Molecular determinants of protein half-lives in eukaryotic cells. FASEB J 1, 349-357.
9. Taylor GA, Hudson E, Resau JH, and Vande Woude GF (2000). Regulation of P311 expression by Met-hepatocyte growth factor/scatter factor and the ubiquitin/proteasome system. J Biol Chem 275, 4215-4219.
10. Westphal M, Meissner H, Matschke J, and Herrmann HD (1998). Tissue culture of human neurocytomas induces the expression of glial fibrillary acidic protein. J Neurocytol 27, 805-816.
11. Berens ME, Rief MD, Loo MA, and Giese A (1994). The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin Exp Metastasis 12, 405-415.
12. Berens ME and Beaudry C (2004). Radial monolayer cell migration assay. Methods Mol Med 88, 219-224.
13. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, and Vogelstein B (1998). A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95, 2509-2514.
14. Lipinski CA, Tran NL, Bay C, Kloss J, McDonough WS, Beaudry C, Berens ME, and Loftus JC (2003). Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma sine migration and proliferation. Mol Cancer Res 1, 323-332.
15. Keller RS, Shai SY, Babbitt CJ, Pham CG, Solaro RJ, Valencik ML, Loftus JC, and Ross RS (2001). Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. Am J Pathol 158, 1079-1090.
16. Tran NL, Adams DG, Vaillancourt RR, and Heimark RL (2002). Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J Biol Chem 277, 32905-32914.
17. Sakoff JA and McCluskey A (2004). Protein phosphatase inhibition: structure based design. Towards new therapeutic agents. Curr Pharm Des 10, 1139-1159.
18. Hers I, Tavare JM, and Denton RM (1999). The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity. FEBS Lett 460, 433-436.
19. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, and Johannes FJ (1996). Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase C isoenzymes. FEBS Lett 392, 77-80.
20. Birchall AM, Bishop J, Bradshaw D, Cline A, Coffey J, Elliott LH, Gibson VM, Greenham A, Hallam TJ, Harris W, et al. (1994). Ro-32-0432, a selective and orally active inhibitor of protein kinase C, prevents T-cell activation. J Pharmacol Exp Ther 268, 922-929.
21. Merril CR, Dunau ML, and Goldman D (1981). A rapid sensitive silver stain for polypeptides in polyacrylamide gels. Anal Biochem 110, 201-207.
22. Chuang YY, Tran NL, Rusk N, Nakada M, Berens ME, and Symons M (2004). Role of synaptojanin 2 in glioma cell migration and invasion. Cancer Res 64, 8271-8275.
23. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
24. Giese A, Rief MD, Loo MA, and Berens ME (1994). Determinants of human astrocytoma migration. Cancer Res 54, 3897-3904.
25. Treasurywala S and Berens ME (1998). Migration arrest in glioma cells is dependent on the alpha v integrin subunit. Glia 24, 236-243.
26. Joy AM, Beaudry CE, Tran NL, Ponce FA, Holz DR, Demuth T, and Berens ME (2003). Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116, 4409-4417.
27. Giese A, Laube B, Zapf S, Mangold U, and Westphal M (1998). Glioma cell adhesion and migration on human brain sections. Anticancer Res 18, 2435-2447.
28. Uhm JH, Gladson CL, and Rao JS (1999). The role of integrins in the malignant phenotype of gliomas. Front Biosci 4, D188-D199.
29. Akiyama SK, Yamada SS, Yamada KM, and LaFlamme SE (1994). Transmembrane signal transduction by integrin cytoplasmic domains expressed in single-subunit chimeras. J Biol Chem 269, 15961-15964.
30. Shaw LM, Rabinovitz I, Wang HH, Toker A, and Mercurio AM (1997). Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion. Cell 91, 949-960.
31. Sahai E and Marshall CJ (2002). RHO-GTPases and cancer. Nat Rev Cancer 2, 133-142.
32. Benard V, Bohl BP, and Bokoch GM (1999). Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J Biol Chem 274, 13198-13204.
33. Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F, and Collard JG (1998). Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell - cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol 143, 1385-1398.
34. Feng Y and Walsh CA (2004). The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol 6, 1034-1038.
35. Upadhyaya A and van Oudenaarden A (2004). Actin polymerization: forcing flat faces forward. Curr Biol 14, R467-R469.
36. Couldwell WT, Uhm JH, Antel JP, and Yong VW (1991). Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery 29, 880-886 (discussion 886-887).
37. Donson AM, Banerjee A, Gamboni-Robertson F, Fleitz JM, and Foreman NK (2000). Protein kinase C zeta isoform is critical for proliferation in human glioblastoma cell lines. J Neuro-Oncol 47, 109-115.
38. Zhang W, Law RE, Hinton DR, and Couldwell WT (1997). Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor. Cancer Lett 120, 31-38.
39. Cho KK, Mikkelsen T, Lee YJ, Jiang F, Chopp M, and Rosenblum ML (1999). The role of protein kinase C alpha in U-87 glioma invasion. Int J Dev Neurosci 17, 447-461.
40. Besson A, Wilson TL, and Yong VW (2002). The anchoring protein RACK1 links protein kinase C epsilon to integrin beta chains. Requirements for adhesion and motility. J Biol Chem 277, 22073-22084.
41. Stossel TP and Hartwig JH (2003). Filling gaps in signaling to actin cytoskeletal remodeling. Dev Cell 4, 444-445.
42. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, and Shapiro SS (2001). Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol 2, 138-145.
43. Cunningham CC, Gorlin JB, Kwiatkowski DJ, Hartwig JH, Janmey PA, Byers HR, and Stossel TP (1992). Actin-binding protein requirement for cortical stability and efficient locomotion. Science 255, 325-327.
44. Nobes CD and Hall A (1995). Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem Soc Trans 23, 456-459.
45. O'Connor KL and Mercurio AM (2001). Protein kinase A regulates Rac and is required for the growth factor - stimulated migration of carcinoma cells. J Biol Chem 276, 47895-47900.